Erythropoietin in stem cell transplantation

[1]  W. Lehmacher,et al.  Increased Serum Levels of Tumor Necrosis Factor a ! Precede Major Complications of Bone Marrow Transplantation , 2003 .

[2]  I. Macdougall,et al.  Novel erythropoiesis stimulating protein. , 2000, Seminars in nephrology.

[3]  I. Macdougall,et al.  Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.

[4]  F. V. Lintig,et al.  Mobilization of peripheral blood progenitor cells in patients with breast cancer: a prospective randomized trial comparing rhG-CSF with the combination of rhG-CSF plus rhEpo after VIP-E chemotherapy , 1999, Bone Marrow Transplantation.

[5]  M. Okada,et al.  Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation. , 1998, International journal of hematology.

[6]  J. Tworek,et al.  Venoocclusive disease of the liver following renal transplantation. , 1998, Digestive diseases and sciences.

[7]  F. Mercuriali.  Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery. , 1996, Seminars in hematology.

[8]  A. Kessinger,et al.  Mobilization of hematopoietic progenitor cells with Epoetin alfa. , 1996, Seminars in hematology.

[9]  M. Offidani,et al.  Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. , 1995, Bone marrow transplantation.

[10]  B. W. Brown,et al.  A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. , 1994, Blood.

[11]  P. Ljungman,et al.  Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin. , 1994, Bone marrow transplantation.

[12]  F. Locatelli,et al.  Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. , 1994, Bone marrow transplantation.

[13]  M. Goldberg,et al.  Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs. , 1994, Blood.

[14]  F. Mandelli,et al.  A controlled trial of recombinant human erythropoietin after bone marrow transplantation. , 1994, Blood.

[15]  E. Dmitrovsky,et al.  Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. , 1993, Blood.

[16]  D. Speicher,et al.  Identification of the amino acid mutations associated with human erythrocyte spectrin alpha II domain polymorphisms. , 1993, Blood.

[17]  M. Otero,et al.  Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trial. , 1992, Bone marrow transplantation.

[18]  S. Piantadosi,et al.  Impaired erythropoietin response to anemia after bone marrow transplantation. , 1992, Blood.

[19]  J. Sanders,et al.  Recombinant human erythropoietin (rh-Epo) administration to normal marrow donors. , 1992, Bone marrow transplantation.

[20]  J. Gribben,et al.  Hemolytic-uremic syndrome following bone marrow transplantation in adults for hematologic malignancies. , 1991, Blood.

[21]  G. Fillet,et al.  Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants , 1991 .

[22]  A. Bosi,et al.  Impaired erythropoietin production in mice treated with cyclosporin A. , 1991, Blood.

[23]  M. Goldberg,et al.  Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. , 1990, Blood.

[24]  P. Greenberg,et al.  Effects of CSFs in preleukemia. , 1990, Bone marrow transplantation.

[25]  W. Lehmacher,et al.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.

[26]  E. Goldwasser,et al.  Amphotericin B blunts erythropoietin response to anemia. , 1990, The Journal of infectious diseases.

[27]  J. Wingard,et al.  Herpesvirus and enteric viral infections in bone marrow transplantation: clinical presentations, pathogenesis, and therapeutic strategies. , 1990, Cancer investigation.

[28]  O. Ringdén,et al.  Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation. , 1990, Bone marrow transplantation.

[29]  J. Richie,et al.  Urological complications of cyclophosphamide. , 1989, The Journal of urology.

[30]  C. Anasetti,et al.  Graft-v-host disease is associated with autoimmune-like thrombocytopenia. , 1989, Blood.

[31]  C. Patte,et al.  Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: incidence, clinical course, and outcome. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  W. Lehmacher,et al.  Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. , 1989, Blood.

[33]  T. Stillwell,et al.  Cyclophosphamide‐induced hemorrhagic cystitis: A review of 100 patients , 1988, Cancer.

[34]  R. Koene,et al.  [Recombinant human erythropoietin]. , 1988, Nederlands tijdschrift voor geneeskunde.

[35]  L. Grochow,et al.  VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION , 1987, Transplantation.

[36]  T. Stillwell,et al.  Cyclophosphamide Induced Hemorrhagic Cystitis , 1987 .

[37]  K. Shah,et al.  Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. , 1986, The New England journal of medicine.

[38]  R. Storb,et al.  The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation , 1986, American journal of hematology.

[39]  R. Arthur,et al.  Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation. , 1986, Archives of internal medicine.

[40]  K. Sullivan,et al.  Intestinal and hepatic complications of human bone marrow transplantation. Part I. , 1986, Gastroenterology.

[41]  J. Lipton,et al.  Isolated thrombocytopenia after allogeneic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. , 1985, Blood.

[42]  H. Prentice,et al.  ABO-INCOMPATIBLE BONE-MARROW TRANSPLANTATION: REMOVAL OF RED BLOOD CELLS FROM DONOR MARROW AVOIDING RECIPIENT ANTIBODY DEPLETION , 1982, The Lancet.

[43]  M. Droller,et al.  Prevention of cyclophosphamide-induced hemorrhagic cystitis. , 1982, Urology.

[44]  H. Braine,et al.  Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion , 1982 .

[45]  R. Notley,et al.  Urological complications of cyclophosphamide. , 1973, British journal of urology.